Summary
Pingyangmycin (bleomycin A5 hydrochloride, PYM) is one of the anti-neoplastic agents which have been commonly used to treat venous malformations. However, the underlying mechanism by which PYM treats venous malformations remains poorly understood. It was reported that venous endothelial cells could recruit neutrophils via adhesion molecules (E-selectin, ICAM-1, ICAM-3, VCAM-1) during the acute/chronic inflammation and subsequent histological fibrosis after sclerotherapy with PYM. This study explored if the expression of E-selectin, ICAM-1, ICAM-3 and VCAM-1 in human venous malformation endothelial cells could be affected by PYM. HVMECs were cultured from human venous malformation tissue. Expressions of E-selectin, ICAM-1, ICAM-3 and VCAM-1 on HVMECs in response to PYM were analyzed by cell ELISA. The relative levels of mRNA expression in the cells were semi-quantified. The results showed that PYM up-regulated the expressions of E-selectin, ICAM-3, VCAM-1 and ICAM-1 in both time- and concentration-dependent manner. Our findings suggested that PYM could induce the expression of adhesion molecules in HVMECs, which might be a possible mechanism by which sclerotherapy by intralesional injection of PYM treats venous malformations.
Similar content being viewed by others
References
Berenguer B, Burrows PE, Zurakowski D, et al. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg, 1999,104(1):1–11
Kim KH, Sung MW, Roh JL, et al. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg, 2004,131(3):307–316
Wei ZJ. Sclerotherapy of maxillofacial venous malformations. J Oral Maxillofac Surg, 2010,68(6):1456–1457
Zheng JW. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin. Head Neck, 2010,32(6):826–827
Hou R, Guo J, Hu K, et al. A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China. J Vasc Surg, 2010,51(4):940–945
Mathur NN, Rana I, Bothra R, et al. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol, 2005,69(1):75–80
Sanlialp I, Karnak I, Tanyel FC, et al. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol, 2003,67(7):795–800
Izbicki G, Segel MJ, Christensen TG, et al. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol, 2002,83(3):111–119
Azuma A, Takahashi S, Nose M, et al. Role of E-selectin in bleomycin induced lung fibrosis in mice. Thorax, 2000,55(2):147–152
Hamaguchi Y, Nishizawa Y, Yasui M, et al. Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis. Am J Pathol, 2002,161(5):1607–1618
Li YJ, Azuma A, Takahashi S, et al. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: Role in preventing lung injury and fibrosis in bleomycin-challenged Mice. Chest, 2002,122(6):2137–2145
Sato N, Suzuki Y, Nishio K, et al. Roles of ICAM-1 for abnormal leukocyte recruitment in the microcirculation of bleomycin-induced fibrotic lung injury. Am J Respir Crit Care Med, 2000,161(5):1681–1688
Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg, 2004,33(5):463–466
Zheng JW, Yang XJ, Wang YA, et al. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients. Oral Oncol, 2009,45(10):872–876
Zhao JH, Zhao YF, Zhang WF. Histological investigation of Veins and venous malformations after injection of sclerosing agents. Asian J Oral Maxillofac Surg, 2002, 14(2):226–231
Jia J, Zhao YF, Zhang WF, et al. Isolation, culture and identification of human venous malformation endothelial cells. Zhonghua Kou Qiang Yi Xue Za Zhi (Chinese), 2002,37(4):284–286
Haraldsen G, Kvale D, Lien B, et al. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol, 1996,156(7):2558–2565
Miyamoto H, Sugawara I, Azuma A, et al. Differential secretion of cytokines and adhesion molecules by HUVEC stimulated with low concentrations of bleomycin. Cell Immunol, 2002,219(2):73–81
Amrani Y, Lazaar AL, Hoffman R, et al. Activation of p55 tumor necrosis factor-β receptor-1 coupled to tumor necrosis factor receptor-associated factor 2 stimulates intercellular adhesion molecule-1 expression by modulating a thapsigargin-sensitive pathway in human tracheal smooth muscle cells. Mol Pharmacol, 2000,58(1):237–245
Scholz D, Devaux B, Hirche A, et al. Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res, 1996,284(3):415–423
Binns RM, Licence ST, Harrison AA, et al. In vivo E-selectin upregulation correlates early with infiltration of PMN, later with PBL entry: MAbs block both. Am J Physiol, 1996,270(1 Pt 2):183–193
Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell, 1987,51(5):813–819.
Dustin ML, Rothlein R, Bhan AK, et al. Induction by IL-1 and interferon-α: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 2011;186(9):5024–5033.
Kasper M, Koslowski R, Luther T, et al. Immunohistochemical evidence for loss of ICAM-1 by alveolar epithelial cells in pulmonary fibrosis. Histochem. Cell Biol, 1995,104(5):397–405
Matsuse T, Teramoto S, Katayama H, et al. ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury. Eur Respir J, 1999,13(1):71–77
Fichtner F, Koslowski R, Augstein A, et al. Bleomycin induces IL-8 and ICAM-1 expression in microvascular pulmonary endothelial cells. Exp Toxicol Pathol, 2004,55(6):497–503
Leeuwenberg JF, Smeets EF, Neefjes JJ, et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology, 1992,77(4):543–549
Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 1998,91(10):3527–3561
Vazeux R, Hoffman PA, Tomita JK, et al. Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature, 1992;360(6403):485–488
Patey N, Vazeux R, Canioni D, et al. Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses. Am J Pathol, 1996, 148(2):465–472
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by the Natural Science Foundation of Hubei province, China (No. 2010CDB07907).
Rights and permissions
About this article
Cite this article
Jia, Y., Jia, J. & Zhao, Y. Pingyangmycin-regulated expressions of adhesion molecules in human venous malformation endothelial cells. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 32, 760–766 (2012). https://doi.org/10.1007/s11596-012-1031-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-012-1031-5